322.40
price down icon0.53%   -1.73
pre-market  Vorhandelsmarkt:  322.49   0.09   +0.03%
loading
Schlusskurs vom Vortag:
$324.13
Offen:
$321.43
24-Stunden-Volumen:
365.91K
Relative Volume:
0.78
Marktkapitalisierung:
$23.39B
Einnahmen:
$2.88B
Nettoeinkommen (Verlust:
$499.60M
KGV:
47.83
EPS:
6.74
Netto-Cashflow:
$321.60M
1W Leistung:
-2.61%
1M Leistung:
-2.81%
6M Leistung:
+12.00%
1J Leistung:
-21.30%
1-Tages-Spanne:
Value
$320.30
$325.20
1-Wochen-Bereich:
Value
$317.59
$335.64
52-Wochen-Spanne:
Value
$265.00
$409.72

West Pharmaceutical Services Inc Stock (WST) Company Profile

Name
Firmenname
West Pharmaceutical Services Inc
Name
Telefon
(610) 594-2900
Name
Adresse
530 HERMAN O. WEST DRIVE, EXTON, PA
Name
Mitarbeiter
10,600
Name
Twitter
@WestPharma
Name
Nächster Verdiensttermin
2024-10-24
Name
Neueste SEC-Einreichungen
Name
WST's Discussions on Twitter

Vergleichen Sie WST mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
322.40 23.39B 2.88B 499.60M 321.60M 6.74
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
591.65 211.02B 8.35B 2.32B 1.30B 6.41
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
229.52 65.90B 20.64B 1.73B 2.94B 6.02
Medical Instruments & Supplies icon
ALC
Alcon Inc
89.81 44.42B 9.76B 1.16B 665.00M 2.34
Medical Instruments & Supplies icon
RMD
Resmed Inc
237.43 34.88B 4.93B 1.25B 1.38B 8.47

West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-01-08 Eingeleitet Citigroup Buy
2024-12-13 Eingeleitet Wolfe Research Peer Perform
2024-12-12 Hochstufung UBS Neutral → Buy
2024-02-07 Hochstufung Jefferies Hold → Buy
2023-06-16 Hochstufung BofA Securities Neutral → Buy
2023-04-11 Hochstufung Stephens Equal-Weight → Overweight
2022-12-14 Eingeleitet Deutsche Bank Hold
2022-11-30 Eingeleitet UBS Neutral
2022-10-28 Herabstufung BofA Securities Buy → Neutral
2020-11-10 Eingeleitet KeyBanc Capital Markets Overweight
2020-10-14 Eingeleitet Stephens Equal-Weight
2020-07-21 Hochstufung BofA Securities Neutral → Buy
2020-04-24 Hochstufung BofA/Merrill Underperform → Neutral
2019-12-12 Herabstufung BofA/Merrill Neutral → Underperform
2019-07-26 Hochstufung BofA/Merrill Underperform → Neutral
2019-05-01 Herabstufung Jefferies Buy → Hold
2019-04-23 Eingeleitet William Blair Outperform
2018-04-25 Herabstufung BofA/Merrill Neutral → Underperform
2018-01-24 Eingeleitet Goldman Neutral
2017-10-17 Herabstufung BofA/Merrill Buy → Neutral
2017-10-03 Eingeleitet Stephens Equal-Weight
2017-09-15 Hochstufung Jefferies Hold → Buy
2016-10-28 Hochstufung Wells Fargo Market Perform → Outperform
2016-09-21 Herabstufung Wells Fargo Outperform → Market Perform
2016-03-22 Eingeleitet Wells Fargo Outperform
2010-05-14 Bestätigt UBS Neutral
2010-02-23 Eingeleitet Jefferies & Co Buy
2008-12-19 Eingeleitet UBS Neutral
Alle ansehen

West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten

pulisher
Feb 11, 2025

Will Segmental Performance Drive West Pharmaceutical's Q4 Earnings? - MSN

Feb 11, 2025
pulisher
Feb 05, 2025

Injectable Drug Device Maker West Pharma Secures Ban At ITC - Law360

Feb 05, 2025
pulisher
Feb 05, 2025

West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch

Feb 05, 2025
pulisher
Feb 05, 2025

Ex-Dividend Reminder: West Pharmaceutical Services, SouthState and Pinnacle Financial Partners - Nasdaq

Feb 05, 2025
pulisher
Feb 05, 2025

Pharmaceutical Packaging Market Top Companies StudyOwens - openPR

Feb 05, 2025
pulisher
Feb 04, 2025

West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Feb 04, 2025
pulisher
Feb 04, 2025

Pharmaceutical Glass Packaging Market: Current Analysis and Forecast (2023-2030) - UnivDatos Market Insights

Feb 04, 2025
pulisher
Feb 04, 2025

Trust Point Inc. Buys 2,427 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat

Feb 04, 2025
pulisher
Feb 04, 2025

Brokerages Set West Pharmaceutical Services, Inc. (NYSE:WST) PT at $430.20 - Defense World

Feb 04, 2025
pulisher
Feb 03, 2025

West Pharmaceutical Services, Inc. (NYSE:WST) Receives $430.20 Average PT from Brokerages - MarketBeat

Feb 03, 2025
pulisher
Feb 03, 2025

StockNews.com Upgrades West Pharmaceutical Services (NYSE:WST) to "Buy" - MarketBeat

Feb 03, 2025
pulisher
Feb 03, 2025

Swedbank AB Boosts Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat

Feb 03, 2025
pulisher
Feb 03, 2025

Pacer Advisors Inc. Has $1.89 Million Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat

Feb 03, 2025
pulisher
Feb 03, 2025

Conestoga Capital Advisors LLC Buys 25,110 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat

Feb 03, 2025
pulisher
Feb 03, 2025

West Pharmaceutical Services Declares Q1 2025 Dividend - MSN

Feb 03, 2025
pulisher
Feb 03, 2025

On-Body Drug Delivery Devices Market reached US$ 40.54 billion - openPR

Feb 03, 2025
pulisher
Feb 03, 2025

West Pharmaceutical Services to Announce Q4 and Full-Year 2024 Results - MSN

Feb 03, 2025
pulisher
Feb 03, 2025

West Pharmaceutical Services, Inc. (NYSE:WST) to Issue Quarterly Dividend of $0.21 - MarketBeat

Feb 03, 2025
pulisher
Feb 02, 2025

Armstrong World Industries to Announce Q4 and Full-Year 2024 Financial Results - MyChesCo

Feb 02, 2025
pulisher
Feb 02, 2025

Tokio Marine Asset Management Co. Ltd. Raises Stake in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat

Feb 02, 2025
pulisher
Feb 02, 2025

Fulton Breakefield Broenniman LLC Takes Position in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat

Feb 02, 2025
pulisher
Jan 31, 2025

West Pharmaceutical Services (NYSE:WST) Raised to “Buy” at StockNews.com - Defense World

Jan 31, 2025
pulisher
Jan 30, 2025

West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch

Jan 30, 2025
pulisher
Jan 30, 2025

West to Host Fourth-Quarter and Full-Year 2024 Conference Call -January 30, 2025 at 06:01 am EST - Marketscreener.com

Jan 30, 2025
pulisher
Jan 30, 2025

West to Host Fourth-Quarter and Full-Year 2024 Conference Call - Quantisnow

Jan 30, 2025
pulisher
Jan 30, 2025

Enviri Corporation to Release Q4 and Full Year 2024 Results - MyChesCo

Jan 30, 2025
pulisher
Jan 29, 2025

West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Jan 29, 2025
pulisher
Jan 29, 2025

West Introduces Daikyo PLASCAP RUV closures in new nested format at Pharmapack - European Pharmaceutical Manufacturer

Jan 29, 2025
pulisher
Jan 29, 2025

West Pharmaceutical sets first-quarter dividend at $0.21/share By Investing.com - Investing.com Canada

Jan 29, 2025
pulisher
Jan 28, 2025

West Pharmaceutical sets first-quarter dividend at $0.21/share - MSN

Jan 28, 2025
pulisher
Jan 28, 2025

West Pharmaceutical Services Maintains Quarterly Dividend at $0.21 Per Share; Payable Feb. 11 to Shareholders of Record on Feb. 7 - Marketscreener.com

Jan 28, 2025
pulisher
Jan 28, 2025

West Announces First-Quarter Dividend - Finansavisen

Jan 28, 2025
pulisher
Jan 28, 2025

West Pharmaceutical Services (NYSE:WST) shareholders have earned a 17% CAGR over the last five years - Simply Wall St

Jan 28, 2025
pulisher
Jan 27, 2025

Indo-Asian News Service-WEST ANNOUNCES FIRST-QUARTER DIVIDEND - IANS India Pvt Ltd

Jan 27, 2025
pulisher
Jan 27, 2025

Vial Closure From: West Pharmaceutical Services, Inc - Healthcare Packaging

Jan 27, 2025
pulisher
Jan 27, 2025

Janney Montgomery Scott LLC Makes New $14.76 Million Investment in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat

Jan 27, 2025
pulisher
Jan 27, 2025

Atomi Financial Group Inc. Raises Position in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World

Jan 27, 2025
pulisher
Jan 26, 2025

West Pharmaceutical Unveils New Nested Format for Daikyo PLASCAP RUV Closures - MSN

Jan 26, 2025
pulisher
Jan 26, 2025

Universal Health Services, Inc. Schedules Q4 and Full-Year 2024 Results Announcement - MyChesCo

Jan 26, 2025
pulisher
Jan 25, 2025

What You Need to Know Ahead of West Pharmaceutical Services’ Earnings Release - MSN

Jan 25, 2025
pulisher
Jan 24, 2025

Beacon Investment Advisory Services Inc. Sells 2,138 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat

Jan 24, 2025
pulisher
Jan 23, 2025

West Pharmaceutical Services Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Jan 23, 2025
pulisher
Jan 23, 2025

West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Riverbridge Partners LLC - MarketBeat

Jan 23, 2025
pulisher
Jan 22, 2025

West launches Daikyo PLASCAP RUV closures in new nested format - Packaging Gateway

Jan 22, 2025
pulisher
Jan 22, 2025

West Pharmaceutical Services, Inc. Introduces Daikyo PLASCAP RUV Closures in New Nested Format At Pharmapack - Marketscreener.com

Jan 22, 2025

Finanzdaten der West Pharmaceutical Services Inc-Aktie (WST)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_instruments_supplies COO
$93.45
price down icon 0.19%
$210.52
price down icon 0.71%
medical_instruments_supplies BAX
$30.60
price down icon 0.68%
$64.47
price down icon 1.18%
$18.39
price down icon 3.26%
Kapitalisierung:     |  Volumen (24h):